. This corroborates the concept that CTO represents a marker of a more advanced atherosclerotic disease in high-risk patients, often presenting with several other comorbidities.
These CTO facts are calling for accurate risk stratification and better selection of patients who would benefit the most from revascularization (6) .
THE PRESENT STUDY
In this issue of JACC: Cardiovascular Interventions, were attempted with PCI, whereas the others deferred to medical therapy or were sent to surgery). In selected patients, experienced operators have reported success rates higher than 90%, using newer devices and more advanced techniques (e.g., retrograde approach). In the present series, the reported success rate of 80% is more likely to reflect a real-world situation in most catheterization laboratories. Whether the results in these patients would have been even better with higher PCI success rate remains to be addressed and balanced with associated higher complication rates.
PRACTICAL IMPLICATIONS
When managing a patient with CTO, should we guide the revascularization on the presence and extent of myocardial ischemia or on the presence of collaterals?
In patients with stable coronary artery disease, a percutaneous revascularization strategy guided by the presence of ischemia and performed with newergeneration drug-eluting stents has been associated with improved clinical outcome (14, 15) . The FAME-2 
